1. Home
  2. CTMX vs FDSB Comparison

CTMX vs FDSB Comparison

Compare CTMX & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • FDSB
  • Stock Information
  • Founded
  • CTMX 2008
  • FDSB 1926
  • Country
  • CTMX United States
  • FDSB United States
  • Employees
  • CTMX N/A
  • FDSB N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • FDSB
  • Sector
  • CTMX Health Care
  • FDSB
  • Exchange
  • CTMX Nasdaq
  • FDSB NYSE
  • Market Cap
  • CTMX 85.3M
  • FDSB 70.0M
  • IPO Year
  • CTMX 2015
  • FDSB N/A
  • Fundamental
  • Price
  • CTMX $0.84
  • FDSB $12.91
  • Analyst Decision
  • CTMX Buy
  • FDSB
  • Analyst Count
  • CTMX 6
  • FDSB 0
  • Target Price
  • CTMX $5.77
  • FDSB N/A
  • AVG Volume (30 Days)
  • CTMX 1.2M
  • FDSB 28.4K
  • Earning Date
  • CTMX 03-10-2025
  • FDSB 02-15-2025
  • Dividend Yield
  • CTMX N/A
  • FDSB N/A
  • EPS Growth
  • CTMX N/A
  • FDSB N/A
  • EPS
  • CTMX 0.16
  • FDSB N/A
  • Revenue
  • CTMX $126,617,000.00
  • FDSB $10,898,681.00
  • Revenue This Year
  • CTMX $22.55
  • FDSB N/A
  • Revenue Next Year
  • CTMX N/A
  • FDSB N/A
  • P/E Ratio
  • CTMX $5.20
  • FDSB N/A
  • Revenue Growth
  • CTMX 33.66
  • FDSB N/A
  • 52 Week Low
  • CTMX $0.79
  • FDSB $9.85
  • 52 Week High
  • CTMX $5.85
  • FDSB $13.40
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 33.95
  • FDSB N/A
  • Support Level
  • CTMX $0.79
  • FDSB N/A
  • Resistance Level
  • CTMX $1.17
  • FDSB N/A
  • Average True Range (ATR)
  • CTMX 0.08
  • FDSB 0.00
  • MACD
  • CTMX -0.03
  • FDSB 0.00
  • Stochastic Oscillator
  • CTMX 13.16
  • FDSB 0.00

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About FDSB FIFTH DISTRICT BANCORP INC.

Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay..

Share on Social Networks: